21.95 -0.09 (-0.41%)
After hours: 6:44PM EDT
|Bid||0.00 x 900|
|Ask||22.07 x 800|
|Day's Range||21.92 - 23.25|
|52 Week Range||21.52 - 750.00|
|PE Ratio (TTM)||N/A|
|Expense Ratio (net)||0.95%|
JDRF T1D Fund is a private equity fund that pays for diabetes research. Yahoo Finance’s Alexis Christoforous talks with JDRF T1D Fund chairman Sean Doherty about the company’s projects. For more information, copy and paste this link into your browser: www.t1dfund.org Or, email: firstname.lastname@example.org
Alan Valdes, director of floor operations at Silverbear Capital, joins Yahoo Finance's Alexis Christoforous from the floor of the New York Stock Exchange to discuss why stocks are down today.
The world's most powerful central bankers met in Frankfurt, Germany on Tuesday. Yahoo Finance's Jared Blikre weighs in on what the heads of the US Federal Reserve, European Central Bank, Bank of England and Bank of Japan had to say.
Keith Bliss of Cuttone and Company joins Yahoo Finance's Alexis Christoforous from the floor of the New York Stock Exchange to discuss what's set to move stocks this week.
Nvidia shares soared early Friday after reporting third quarter results that exceeded Wall Street expectations in nearly every category. Yahoo Finance's Jared Blikre explains why he thinks Nvidia and Intel are the stocks to watch going forward.
All three major indexes started the day lower on Friday as investors continued to fret over the details of the Senate tax bill. Yahoo Finance's Jared Blikre explains that tax reform is not the only concern Wall Street has right now.
Stocks may be taking a breather today, but that doesn't mean the bulls have run out of steam. Yahoo Finance's Justine Underhill had more.
Broadcom made an unsolicited bid for Qualcomm early Monday. The $70 a share offer values the deal at a whopping $130 billion. Yahoo Finance's Alexis Christoforous and Jared Blikre discuss what are the odds this deal will get regulatory approval, and what it could mean for the chip industry.
Among leveraged and inverse biotechnology exchange-traded funds, the Direxion Daily S&P Biotech Bull 3X Shares (NYSE: LABU ) and the Direxion Daily S&P Biotech Bear 3X Shares (NYSE: LABD ) are the dominant ...
NEW YORK , Feb. 28, 2018 /PRNewswire/ -- Direxion has announced it will execute a reverse split of the issued and outstanding shares of the Direxion Daily Technology Bear 3X Shares, Direxion Daily Energy ...
Short interest is a popular metric on Wall Street because it gives a peek into the amount of negative sentiment a stock has. For their part, leveraged ETFs thrive on the directionality short interest can ...
The latest Republican tax reform bill takes yet another stab at the Affordable Care Act with a proposed repeal of individual mandates, party leadership said Tuesday . The mandates had required Americans ...
Even with modest August losses for the S&P 500 and the broader healthcare sector, biotechnology stocks and exchange traded funds (ETFs) are surging. The S&P Biotechnology Select Industry Index is up more ...
U.S. ETFs are on pace to have record inflows in 2017. That includes funds dedicated to equities, fixed income, and commodities. And it's easy to see why. With the S&P 500 up 9 percent this year (through ...